(g) As hinted in (d) above, the cause of the syndrome is unknown. The author of the NYT article ascribes the cause to macrophage. But it is more prudent to say we simply do not know.
(i) Often cause of a disease, though unknown, can be deduced from effective treatment. This syndrome is one example.
(ii) A protein of 17 KD (kilodaltons or kilograms per mol; check Wikipedia for "molar mass"), anakinra is a man-made (read: recombinant) human IL-1 receptor antagonist. Healthy humans secret both IL-1 and "IL-1 receptor antagonist" (maybe in different time or sites), both of which bind to IL-1 receptor -- the former is an agonist (causing effects) but the latter an antagonist (preventing effects). The big molecular weight means anakinra must be injected (can not be taken by mouth; digestive system will reduce the drug to amino acids).
(iii) "Anakinra differs from native human IL-1Ra in that it has the addition of a single methionine residue at its amino terminus." Wikipedia.
(iv) Macrophage secrets interleukin-1 (IL-1), which actually are "two distinct, but distantly related" (quoting Wikipedia; but with similar functions) proteins encoded by two different genes.
(v) IL-1 binds to two similar receptors (encoded by two different genes), of which the main type, IL-1 receptor type I (as opposed to type II), is expressed on the surface of on T cells, fibroblasts and endothelial cells. Science, 241: 585-589 (1988)
(vi) Schnitzler syndrome apparently has overproduction of IL-1, compared to in normal persons. Yet one can not blame it on macrophage alone, which can be cause or effect (some other cells causes macrophage to secret more IL-1).
(vii) Gouveia AI et al, Schnitzler Syndrome: A Dramatic Response to Anakinra. Heidelberg: Dermatology and Therapy, 6: 299–302 (2016).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906102/
(A) View only Figure 2, whose caption is "Histological features. Mixed inflammatory infiltrate (predominantly of neutrophils) in the dermis with no evidence of vasculitis. a H&E ×10, b H&E ×40."
(B) White blood cells (or leukocytes) "can be divided into the five main types: neutrophils, eosinophils, basophils, lymphocytes, and monocytes." Wikipedia.
(C) For hematoxylin and eosin (H&E, where H and E are two separate dyes of simple chemicals, both of which are red to naked eyes) stain, see What is H&E? In The Histology Guide, Faculty of Biological Sciences, University of Leeds, undated.
http://histology.leeds.ac.uk/what-is-histology/H_and_E.php
Both eosinophils and basophils contain large granules inside their cytoplasm, with the former's stained red (eosinophilic ) and the latter's purple (basophilic). Neutrophils have neither, and are so named ("neutro"). Pay attention Figure 2 shows infiltration by neutrophils, but not macrophages.
(h) The (g)(vii) above cited in reference 1 a seminal review:
Dan Lipsker, The Schnitzler syndrome. Orphanet Journal of Rare Diseases, 5: 38 (2010).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018454/
Quote
"It was exceedingly difficult to treat patients with this syndrome until the IL-1 receptor antagonist anakinra became available. Anakinra allows a complete control of all signs within hours after the first injection, but patients need continuous treatment with daily injections. * * * signs recur as soon as the treatment is stopped.
"And indeed, IL-1 inhibition is a very effective treatment modality in patients with CINCA [another disease whose full name is Chronic Infantile Neurological Cutaneous and Articular syndrome]. Since the Schnitzler syndrome shares many features with the CINCA syndrome, anakinra, an IL-1 inhibitor was also tried in the former syndrome. It proved to be the first really efficient treatment of the Schnitzler syndrome.
"mean age of disease onset is 51 years.
* A mean 中间数 is different from an average 平均值. |